Anti-inflammatory drugs were originated firstly by serendipitous discovery of certain plants and their extracts being applied for the relief of pain, fever and inflammation. When salicylates were discovered in the mid-19th century to be the active components of willow spp., this enabled compounds to be synthesized and from this, acetyl-salicylic acid or aspirin trademark was developed. Similarly, the chemical advances of the 19-20th centuries lead to discovery of the NSAID’s, most of the NSAID’s were organic acids initially, but later on non-acidic compounds were discovered. 

MARKET DYNAMICS - EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET 

The Europe anti-inflammatory therapeutics market is witnessing lucrative growth during forecast period of 2021 to 2027. The inflammation is a natural immune response of human which is chiefly activated to clear dead cells and eliminate the cause of injury. The key factors such as new drug pipelines is propelling the growth of Europe anti-inflammatory therapeutics market. Increasing adoption rate of anti-inflammatory drugs is also boosting growth of Europe anti-inflammatory therapeutics market. However, patent expiry of drugs is restraining the growth of Europe anti-inflammatory therapeutics market. 

Get Free Sample Report for More Industry Insights: https://www.axiommrc.com/request-for-sample/10797-europe-anti-inflammatory-therapeutics-market-report

COVID-19 IMPACT ON EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET

The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the anti-inflammatory therapeutics market. In addition, complete analysis of changes on anti-inflammatory therapeutics organizations expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. Owing to inflammation caused by COVID-19 virus which causes severe pneumonia the anti-inflammatory therapeutics market is witnessing rapid growth. The cytokine rage is chief cause of death in COVID-19 affected patients. Some of the consequences of severe inflammation and cytokine storm comprised of the acute respiratory distress syndrome, acute lung injury and multiple organ dysfunction syndrome which leads to research and development of anti-inflammatory drugs for treatment of the inflammation caused by the COVID-19. Thus, such factors have impacted positively on the growth of anti-inflammatory therapeutics market during the COVID-19 pandemics. 

EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET - SEGMENTAL OVERVIEW 

The Europe anti-inflammatory therapeutics market is categorised into drug class, indication, end users and country. 

EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS 

Based on drug class, the Europe anti-inflammatory therapeutics market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs, corticosteroids, immune-selective anti-inflammatory derivative and other. In which corticosteroids is also contributing in the growth of Europe anti-inflammatory therapeutics market. The corticosteroids are synthesized drugs which are structurally similar to the cortisol which is a hormone that is produced by adrenal gland. They are helps in preventing synthesis of chemical mediators which causes inflammation. This makes them more demandable in the market. 

EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY INDICATION 

Based on indication, the Europe anti-inflammatory therapeutics market is segmented into arthritis, chronic obstructive pulmonary diseases, multiple sclerosis, inflammatory bowel diseases, asthma, tendonitis and other. In which asthma is also contributing in the growth of Europe anti-inflammatory therapeutics market. The asthma is a condition in which your airways narrow and swell and can cause extra mucus. It may cause difficulty in breathing, trigger coughing and whistling sound at the time of breathing along with shortness of breath. The asthma may cause dull ache or sharp, stabbing pain along with heavy brick sitting on the chest. The rising prevalence of asthma is propelling growth of Europe anti-inflammatory therapeutics market. 

EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY END USER 

Based on end user, the Europe anti-inflammatory therapeutics market is categorised into hospital pharmacies, online pharmacies and retail pharmacies. The retail pharmacies is also contributing in the growth of Europe anti-inflammatory therapeutics market. The rising prevalence of chronic diseases is propelling growth of Europe anti-inflammatory therapeutics market. The new product launch is also boosting growth of Europe anti-inflammatory therapeutics market. 

EUROPE ANTI-INFLAMMATORY THERAPEUTICS MARKET BY COUNTRY

The Europe anti-inflammatory therapeutics market is studied for key countries such as UK, Germany, France, Italy and Spain. In which UK is anticipated to dominate the market in 2020. The rising prevalence of arthritis is propelling growth of Europe anti-inflammatory therapeutics market. The growing elderly population is boosting growth of Europe anti-inflammatory therapeutics market. The rising economy development is also driving growth of Europe anti-inflammatory therapeutics market. 

KEY PLAYERS IN ANTI-INFLAMMATORY THERAPEUTICS MARKET 

The major key players operating in the market are Amgen Inc, Astrazeneca Plc., Eli Lily And Company., Hoffmann-La Roche Ag, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Ag and Pfizer Inc among others. 

Request For Best Pricing :- https://www.axiommrc.com/request-for-sample/10797-europe-anti-inflammatory-therapeutics-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research Consulting™ aims to become the preferred market research and data Analytics Company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Follow On

LinkedIn:https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom